Tiny ‘mini-me’ organs grown from children’s cells are transforming cystic fibrosis care

More than 2,000 known CFTR mutations have been identified worldwide. The type of mutation a patient carries can alter everything from how severe their symptoms are to what drugs will work for them.

“The CFTR protein acts like the airport gate at the top of the body’s epithelial cells—the cells lining the lungs, gut and pancreas,” she says. “When the gate opens, salts and water—the planes—flow out, to hydrate the mucus that traps bacteria in these organs and clear them out of the body.” But, with cystic fibrosis, the “airport” can not only malfunction—sometimes it doesn’t exist at all.

A/Prof. Waters’ lab has spent years developing more personalized ways of matching children to the right CFTR modulator drug. The lab method grows a patient’s own stem cells and turns them into tiny replicas of their lungs or gut.

Sign up for Blog Updates